EVP and Chief Medical Officer of Horizon Therapeutics Plc (30-Year Financial, Insider Trades) Jeffrey W Sherman (insider trades) sold 9,100 shares of HZNP on 07/06/2020 at an average price of $57.5 a share. The total sale was $523,250.
Horizon Pharma PLC is a pharmaceutical company. The company focuses on researching, developing and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases. Horizon Therapeutics PLC has a market cap of $11.23 billion; its shares were traded at around $57.29 with a P/E ratio of 20.24 and P/S ratio of 8.62. GuruFocus has detected 1 severe warning sign with Horizon Therapeutics PLC. .
Directors and Officers Recent Trades:
- EVP and Chief Medical Officer Jeffrey W Sherman sold 9,100 shares of HZNP stock on 07/06/2020 at the average price of $57.5. The price of the stock has decreased by 0.37% since.
- EVP, Chief Admin. Officer Barry Moze sold 23,158 shares of HZNP stock on 07/01/2020 at the average price of $54.64. The price of the stock has increased by 4.85% since.
- Director Michael G Grey sold 1,755 shares of HZNP stock on 06/25/2020 at the average price of $55. The price of the stock has increased by 4.16% since.
- See remarks Jeff Kent sold 2,785 shares of HZNP stock on 06/10/2020 at the average price of $48.05. The price of the stock has increased by 19.23% since.
For the complete insider trading history of HZNP, click here
.
